Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children

Clinical and Vaccine Immunology

Volumn 21, Issue 2, 2014, Pages 133-142

  Hur, Yun Gyoung ^a,e   Crampin, Amelia C ^a,b   Chisambo, Christina ^b   Kanyika, James ^b   Houben, Rein ^a,b   Ndhlovu, Richard ^b   Mzembe, Themba ^b   Lalor, Maeve K ^a,f   Saul, Jacky ^a   Branson, Keith ^a   Stanley, Carolynne ^a   Ngwira, Bagrey ^b   French, Neil ^b,c   Ottenhoff, Tom H ^d   Dockrell, Hazel M ^a   Gorak Stolinska, Patricia ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Yonsei University College of Medicine   (South Korea)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; LATENT TUBERCULOSIS; MALAWI; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS;

EID: 84893226992     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00620-13     Document Type: Article

References (31)

1. World Health Organisation. 2012. Tuberculosis. World Health Organisation, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs104/en.
2. World Health Organisation. 2012. No more crying, no more dying: towards zero TB deaths in children. World Health Organisation, Geneva, Switzerland. http://www.stoptb.org/assets/documents/news/ChildhoodTB-report-singles.pdf.
3. Pai M, Riley LW, Colford JM, Jr. 2004. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4:761-776. http://dx.doi.org/10.1016/S1473-3099(04)01206-X.
4. Andersen P, Munk ME, Pollock JM, Doherty TM. 2000. Specific immune-based diagnosis of tuberculosis. Lancet 356:1099-1104. http://dx.doi.org/10.1016/ S0140-6736(00)02742-2.
5. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64:16-22. (Pubitemid 26009335)
6. Lein AD, von Reyn CF, Ravn P, Horsburgh CR, Alexander LN, Andersen P. 1999. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 6:606-609. (Pubitemid 29330751)
7. Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff TH, van Dissel JT. 2002. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J. Infect. Dis. 186:1797-1807. http://dx.doi.org/10.1086/345760.
8. Vordermeier HM, Brown J, Cockle PJ, Franken WP, Drijfhout JW, Arend SM, Ottenhoff TH, Jahans K, Hewinson RG. 2007. Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level. Clin. Vaccine Immunol. 14:1203-1209. http://dx.doi.org/10.1128/ CVI.00116-07. (Pubitemid 47518088)
9. Geluk A, van Meijgaarden KE, Franken KL, Subronto YW, Wieles B, Arend SM, Sampaio EP, de Boer T, Faber WR, Naafs B, Ottenhoff TH. 2002. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infect. Immun. 70:2544-2548. http://dx.doi.org/10.1128/IAI.70.5.2544-2548.2002. (Pubitemid 34408399)
10. World Health Organisation. 2011. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. World Health Organisation, Geneva, Switzerland. http://whqlibdoc.who.int/ publications/2011/9789241502672-eng.pdf.
11. Crampin AC, Glynn JR, Traore H, Yates MD, Mwaungulu L, Mwenebabu M, Chaguluka SD, Floyd S, Drobniewski F, Fine PE. 2006. Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg. Infect. Dis. 12:729-735. http://dx.doi.org/10.3201/eid1205.050789. (Pubitemid 43726845)
12. Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, Blitz R, Mvula H, Newport MJ, Branson K, McGrath N, Crampin AC, Fine PE, Dockrell HM. 2009. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J. Infect. Dis. 199:795-800. http://dx.doi.org/10.1086/ 597069.
13. Lalor MK, Floyd S, Gorak-Stolinska P, Ben-Smith A, Weir RE, Smith SG, Newport MJ, Blitz R, Mvula H, Branson K, McGrath N, Crampin AC, Fine PE, Dockrell HM. 2011. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J. Infect. Dis. 204:1075-1085. http://dx.doi.org/10.1093/infdis/jir515.
14. Lalor MK. 2009. Infant immune responses following BCG vaccination in the UK and Malawi. Ph.D thesis. University of London, London, United Kingdom.
15. Fine PE, Floyd S, Stanford JL, Nkhosa P, Kasunga A, Chaguluka S, Warndorff DK, Jenkins PA, Yates M, Ponnighaus JM. 2001. Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy. Epidemiol. Infect. 26:379-387. (Pubitemid 32640701)
16. Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, Boom WH, Dockrell HM, Franken KL, Friggen AH, Hill PC, Klein MR, Lalor MK, Mayanja H, Schoolnik G, Stanley K, Weldingh K, Kaufmann SH, Walzl G, Ottenhoff TH. 2009. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin. Vaccine Immunol. 16:1203-1212. http://dx.doi.org/10.1128/CVI.00111-09.
17. Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den Hartigh J, Ottenhoff TH, Drijfhout JW. 2000. Purification of His-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr. Purif. 18:95-99. http://dx.doi.org/10.1006/prep. 1999.1162. (Pubitemid 30097778)
18. Smith SG, Joosten SA, Verscheure V, Pathan AA, McShane H, Ottenhoff TH, Dockrell HM, Mascart F. 2009. Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4:e7972. http://dx.doi.org/10.1371/journal.pone.0007972.
19. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM. 2002. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401. http://dx.doi.org/10.1016/S0140-6736(02)08353-8. (Pubitemid 34442380)
20. Ulrichs T, Munk ME, Mollenkopf H, Behr-Perst S, Colangeli R, Gennaro ML, Kaufmann SH. 1998. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28:3949-3958. http://dx.doi.org/10.1002/(SICI)1521-4141(199812)28:12〈3949:: AID-IMMU3949〉3.0.CO;2-4.
21. Mustafa AS, Oftung F, Amoudy HA, Madi NM, Abal AT, Shaban F, Rosen Krands I, Andersen P. 2000. Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. Clin. Infect. Dis. 3:S201-S205. http://dx.doi.org/10.1086/313862. (Pubitemid 32250406)
22. Ravn P, Demissie A, Eguale T, Wondwosson H, Lein D, Amoudy HA, Mustafa AS, Jensen AK, Holm A, Rosen Krands I, Oftung F, Olobo J, von Reyn F, Andersen P. 1999. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645. http://dx.doi.org/10.1086/314640. (Pubitemid 30016147)
23. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 50:213-219. http://dx.doi.org/10.1007/s002510050595. (Pubitemid 30099526)
24. Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Lower M, Welters MJ, Ottensmeier C, van der Burg SH, Britten CM. 2010. Response definition criteria for ELISPOT assays revisited. Cancer Immunol. Immunother. 59:1489-1501. http://dx.doi.org/10.1007/s00262-010-0875-4.
25. Cowan J, Pandey S, Filion LG, Angel JB, Kumar A, Cameron DW. 2012. Comparison of interferon-gamma-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin. Exp. Immunol. 167:317-329. http://dx.doi.org/10.1111/j.1365-2249.2011.04520.x.
26. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. 2009. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39:723-729. http://dx.doi.org/10.1002/eji.200838693.
27. Seah GT, Scott GM, Rook GA. 2000. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 181:385-389. http://dx.doi.org/10.1086/315200. (Pubitemid 30049076)
28. Djoba Siawaya JF, Beyers N, van Helden P, Walzl G. 2009. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin. Exp. Immunol. 156:69-77. http://dx.doi.org/10.1111/j.1365- 2249.2009.03875.x.
29. Ordway DJ, Costa L, Martins M, Silveira H, Amaral L, Arroz MJ, Ventura FA, Dockrell HM. 2004. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190:756-766. http://dx.doi.org/10.1086/ 422532. (Pubitemid 39050006)
30. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO. 2010. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 5:e12365. http://dx.doi.org/10.1371/journal.pone.0012365.
31. Vordermeier HM, Harris DP, Moreno C, Ivanyi J. 1994. Promiscuous T cell recognition of an H-2 IA-presented mycobacterial epitope. Eur. J. Immunol. 24:2061-2067. http://dx.doi.org/10.1002/eji.1830240919. (Pubitemid 24276535)